ANGPTL2 and prostate cancer: Exosomal miR-378a-3p promoted prostate cancer progression and osteolysis by targeting Dyrk1a/Nfatc1 pathway in bone marrow macrophages leading to increased secretion of angiopoietin like 2 (Angptl2) into the bone microenvironment [172].